Trials / Conditions / Transformed Recurrent Non-Hodgkin Lymphoma
Transformed Recurrent Non-Hodgkin Lymphoma
5 registered clinical trials studyying Transformed Recurrent Non-Hodgkin Lymphoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma NCT03147885 | Barbara Ann Karmanos Cancer Institute | Phase 1 / Phase 2 |
| Active Not Recruiting | Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin NCT02992522 | Beth Christian | Phase 1 |
| Completed | Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma NCT02652715 | Mayo Clinic | N/A |
| Active Not Recruiting | Memory Enriched T Cells Following Stem Cell Transplant in Treating Patients With Recurrent B-Cell Non-Hodgkin NCT02051257 | City of Hope Medical Center | Phase 1 |
| Completed | Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma NCT01719250 | Mayo Clinic | EARLY_Phase 1 |